personalized, responsive service and to improve the site, we remember and store information about how you use
Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
In September’s issue of The Small Molecule Manufacturer, we take a deep-dive into the history of Indian pharma and ask industry experts how the country is adapting to the changes caused by the COVID-19 pandemic. Meanwhile, in The Next Big Thing, we examine the pros and cons of continuous manufacturing and discover how the API manufacturing process can be de-risked. We also sit down with JoyL Silva, General Manager at Pfizer CentreOne.